Tianjin Ringpu Bio-Technology Co 300119.SZ · CNY

Its shares trade on Shenzhen under the ticker 300119.SZ. It has been listed since 17 September 2010. In the fiscal year to 31 December 2025, it reported revenue of CN¥3.40bn and net income of CN¥400.5m. At that date it held total assets of CN¥7.66bn and shareholders' equity of CN¥4.70bn.

Tianjin Ringpu Bio-technology Co., Ltd. engages in the provision of animal health services. The company is headquartered in Tianjin, Tianjin. The company went IPO on 2010-09-17. The firm operates through two main segments. The Veterinary Use Biological Products segment is mainly involved in the manufacture and sales of poultry vaccines, veterinary use vaccines, biological products for treatment, diagnostic products and other biological products. The Veterinary Preparations segment is mainly involved in the manufacture and sales of chemical preparations, veterinary Chinese medicine and other preparations.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Shoujun LiChairman of the Board, since 2008CN¥1.7m
• Ms. Gaibian LiFinance Director, since 2022
• Mr. Lei XuGeneral Manager, Director, since 2019CN¥1.2m
• Ms. Ailing LiuDeputy General Manager, DirectorCN¥982,400
• Mr. Xiutong ZhuDeputy General Manager, Director, since 2022CN¥855,800
• Mr. Yongjun YouDeputy General Manager
• Mr. Gang XieSecretary of the Board
• Ms. Rui LiDirectorCN¥337,900
• Mr. Ya LiDirectorCN¥100,000
• Mr. Qing YangDirector
• Mr. Xuepeng CaiIndependent Director
• Mr. Chunlin GuoIndependent DirectorCN¥16,700

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.